PHARMACOECONOMIC EFFECTIVENESS OF NAFTIDROFURYL IN PATIENTS WITH ISCHEMIC STROKE

The study objective is to conduct a pharmacoeconomic analysis of naftidrofuryl effectiveness in patients with ischemic stroke.

Materials and methods. The work is based on the results of clinical studies of effectiveness, tolerability, and safety of naftidrofuryl in patients who suffered an ischemic stroke. The study design included data on 1000 patients of 45 and older with first-time acute cerebrovascular disease of ischemic type.

Results. Direct medical costs for the chosen patient cohort per the Standard of stroke treatment current at the time of the study were 730 575 189 rubles, in case of naftidrofuryl inclusion they were 476 467 620 rubles. Cost minimization is 254 107 569 rubles. Indirect nonmedical costs associated with temporary incapacity for work for treatment per the Standard of stroke treatment were 124 156 950 rubles, and 64 559 180 rubles for naftidrofuryl use which demonstrates the drug’s economic benefit. Budget impact analysis has shown that the possible savings constitute 7.59 %.

Conclusion. Inclusion of naftidrofuryl into treatment of patients with ischemic stroke is justified as it decreases duration of rehabilitation. This leads to a positive economic effect expressed as decreased direct and non-direct medical costs.

1. Vakhnina N.V. Treatment of ischemic stroke. Russkiy meditsinskiy zhurnal = Russian Medical Journal 2008;16(12):1641–4. (In Russ.).

2. Spirin N.N., Korneeva N.N. Data of hospital register of stroke in Kostroma. Fundamental’nye issledovaniya = Fundamental Research 2012;4(1):123–8. (In Russ.).

3. World Health Organization: World health report 2004-changing history. Geneva: World Health Organization, 2004.

4. Gusev E.I., Martynov M.Yu., Kamchatnov P.R. Ischemic stroke. Current state of the problem. Doktor.ru = Doctor.ru 2013;5(83):7–12. (In Russ.).

5. Stakhovskaya L.V., Kotov S.V. Stroke. A guide for physicians. Moscow: MIA, 2014. (In Russ.).

6. Stakhovskaya L.V., Klochikhina O.A., Bogatyreva M.D., Chugunova S.A. Analysis of epidemiological indicators of recurrent stroke in the regions of the Russian Federation (results of the territorial-population registry 2009–2014). Consilium Medicum 2016;18(9):8–11. (In Russ.).

7. Gusev E.I., Skvortsova V.I., Stakhovskaya L.V. The problem of stroke in the Russian Federation: the active joint action. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2007;107(8):1–11. (In Russ.).

8. Ginsberg M.D. New in the pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection. Stroke. Rossiyskoe izdanie = Stroke. The Russian edition 2004;(1):76–82. (In Russ.).

9. Marconi A., Darquenne S., Boulmerka A. et al. Naftidrofyril-driven regulation of endothelial ICAM-1 involves nitric oxide. Free Radic Biol Med 2003;34(5):616–25. PMID: 12614850.

10. Taguchi T., Takaqi N., Miyake K. et al. Effects of naftidrofuryl oxalate on microsphere-induced changes in acetylcholine and amino acid content of rat brain regions. Exp Brain Res 1994;99(1):7–16. PMID: 7925797.

11. The branch standard “Clinical and economic studies. General provisions” the Order of Ministry of Health of the Russian Federation dated 27.05.2002 No. 163. Available at: http://www.healtheconomics.ru/index.php?option=com_content&view=article&id=300:-q-q&catid=55:2009-05-29-19-56-44&Itemid=104. (In Russ.).

12. Standard of emergency medical care in stroke (Approved by the order of Ministry of health and social development of the Russian Federation of 20.12.2012 No. 1282н). (In Russ.).

13. The state register of maximum sale prices. Available at: http://grls.rosminzdrav.ru/PriceLims.aspx. (In Russ.).

14. Cheberda A.E., Belousov D.Yu., Bogolepova A.N. Pharmacoeconomic analysis naftidrofuryl in chronic cerebral ischemia. Kachestvennaya klinicheskaya praktika = Good Clinical Practice 2016;(2):29–37. (In Russ.).

15. The order of Department of health of Moscow from 12.08.2015 No. 673 “About modification in the order of Department of health of Moscow 18.05.2015 No. 383”. (In Russ.).

16. The standard of care of stroke patients (Approved by the order of Ministry of health and social development of the Russian Federation dated 22.11.2004 No. 236. (In Russ.).

17. Standard of care the stroke patients (in secondary care) (Approved by the order of Ministry of health and social development of the Russian Federation dated 01.08.2007 No. 513). (In Russ.).

18. Online resource of the Federal state budgetary institution “Central scientific research Institute of traumatology and orthopedics named after N.N. Priorov” of the Ministry of Health of the Russian Federation. Available at: https://www.cito-priorov.ru/page_for_patient_uc.php?price=all. (In Russ.).

19. Online resource of the Federal budgetary health care institution “Volga regional medical center” of Federal Medical-Biological Agency. Available at: http://www.pomc.ru/price-list-na-uslugi/13348. (In Russ.).

20. Lehert P., Comte S., Gamand S., Brown T.M. Naftidrofuryl in intermittent claudication: a retrospective analysis. J Cardiovasc Pharmacol 1994;23 Suppl 3:S48–52. PMID: 7517478.

21. Capon A., Lehert P., Opsomer L. Naftidrofuryl in the treatment of subacute stroke. J Cardiovasc Pharmacol 1990;16 Suppl 3:S62–6. PMID: 1369722.

22. Koval’chuk V., Tokareva E. Drug rehabilitation as an opportunity to improve the functional status of patients after a stroke. Vrach = Physician 2015;(9):52–4. (In Russ.).

23. Parfenov V.A., Lokshina A.B., Gishina D.A. et al. Application naftidrofuryl at moderate vascular cognitive disorders. Meditsinskiy sovet = Medical Council 2017;(1S):22–6. (In Russ.).

24. Admani A.K. New approаch to treatment of recent stroke. Br Med J 1978;2(6153):1678–9. PMID: 367511.

25. Steiner T.J., Clifford R.F. Randomised double-blind placebo controlled clinical trial of naftidrofuril in hemiparetic CT-proven acute cerebral hemisphere infarction. R Soc Med Int Congr Symp Ser 1986;99:85–98.

26. Steiner T.J. Naftidrofuril after acute stroke: a review and a hypotesis. J Cardiovasc Pharmacol 1990;16(3):58–61. PMID: 1369721.

27. De Backer T., Vander Stichele R., Lehert P., Van Bortel L. Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data. BMJ 2009;338:b603. DOI: 10.1136/bmj.b603.

28. Leonardi-Bee J., Steiner T., Bath-Hextall F. Naftidrofuryl for acute stroke. Cochrane Database Syst Rev 2007;(2):CD005478. DOI: 10.1002/14651858.CD005478.pub2. PMID: 17443593.